Craig Hallum Raises Eton Pharmaceuticals (NASDAQ:ETON) Price Target to $15.00
MarketBeatCraig Hallum raised their price target on shares of Eton Pharmaceuticals from $10.00 to $15.00 and gave the stock a “buy” rating in a research report on Monday.
Craig Hallum raised their price target on shares of Eton Pharmaceuticals from $10.00 to $15.00 and gave the stock a “buy” rating in a research report on Monday.